Correlation Between Goldman Sachs and Albireo Pharma
Can any of the company-specific risk be diversified away by investing in both Goldman Sachs and Albireo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Goldman Sachs and Albireo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Goldman Sachs Access and Albireo Pharma, you can compare the effects of market volatilities on Goldman Sachs and Albireo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Goldman Sachs with a short position of Albireo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Goldman Sachs and Albireo Pharma.
Diversification Opportunities for Goldman Sachs and Albireo Pharma
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Goldman and Albireo is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Goldman Sachs Access and Albireo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albireo Pharma and Goldman Sachs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Goldman Sachs Access are associated (or correlated) with Albireo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albireo Pharma has no effect on the direction of Goldman Sachs i.e., Goldman Sachs and Albireo Pharma go up and down completely randomly.
Pair Corralation between Goldman Sachs and Albireo Pharma
If you would invest 9,967 in Goldman Sachs Access on January 26, 2024 and sell it today you would earn a total of 36.00 from holding Goldman Sachs Access or generate 0.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 4.76% |
Values | Daily Returns |
Goldman Sachs Access vs. Albireo Pharma
Performance |
Timeline |
Goldman Sachs Access |
Albireo Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Goldman Sachs and Albireo Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Goldman Sachs and Albireo Pharma
The main advantage of trading using opposite Goldman Sachs and Albireo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Goldman Sachs position performs unexpectedly, Albireo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will offset losses from the drop in Albireo Pharma's long position.Goldman Sachs vs. iShares ESG 1 5 | Goldman Sachs vs. First Trust Low | Goldman Sachs vs. First Trust Managed | Goldman Sachs vs. First Trust Senior |
Albireo Pharma vs. Arhaus Inc | Albireo Pharma vs. Beyond Inc | Albireo Pharma vs. Sea | Albireo Pharma vs. National Vision Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stocks Directory Find actively traded stocks across global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |